![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Becker U. Laakmann G. Baghai T. Pfeiffer B. Kauert G.
Publisher: Elsevier
ISSN: 0924-977X
Source: European Neuropsychopharmacology, Vol.5, Iss.3, 1995-09, pp. : 273-273
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Claudi F. Scoccia L. Giorgioni G. Marucci G. Di Stefano A. Gessi S. Siniscalchi A. Borea P.A.
European Journal of Medicinal Chemistry, Vol. 33, Iss. 9, 1998-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
5-HT1B/1D antagonists and depression
By Halazy S. Lamothe M. Jorand-Lebrun C.
Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 4, 1997-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)